Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lise Aagaard & Ebba Holme Hansen. (2011) The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies. Neuropsychiatric Disease and Treatment 7, pages 729-744.
Read now
Read now
Articles from other publishers (13)
Giuliana Perrotte, Marina Maria Gonzaga Moreira, Amauri de Vargas Junior, Alvaro Teixeira Filho & João Mauricio Castaldelli-Maia. (2023) Effects of Caffeine on Main Symptoms in Children with ADHD: A Systematic Review and Meta-Analysis of Randomized Trials. Brain Sciences 13:9, pages 1304.
Crossref
Crossref
Valeska Cid-Jofré, Macarena Gárate-Pérez, Philip J. Clark, Viviana Valero-Jara, Rodrigo A. España, Ramón Sotomayor-Zárate, Gonzalo Cruz & Georgina M. Renard. (2021) Chronic modafinil administration to preadolescent rats impairs social play behavior and dopaminergic system. Neuropharmacology 183, pages 108404.
Crossref
Crossref
Rocio Heyer-Osorno & Jorge Juárez. (2020) Modafinil reduces choice impulsivity while increasing motor activity in preadolescent rats treated prenatally with alcohol. Pharmacology Biochemistry and Behavior 194, pages 172936.
Crossref
Crossref
Manu Easow Mathew, Tamoghna Biswas, Shabin Fahad & Mitali Patnaik. (2017) Modafinil for excessive daytime sleepiness. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Tae-Youn Jun, Ashwin A. Patkar, Prakash S. Masand & Chi-Un Pae. (2017) Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research 84, pages 292-300.
Crossref
Crossref
S. M. Castellino, N. J. Ullrich, M. J. Whelen & B. J. Lange. (2014) Developing Interventions for Cancer-Related Cognitive Dysfunction in Childhood Cancer Survivors. JNCI Journal of the National Cancer Institute 106:8, pages dju186-dju186.
Crossref
Crossref
Manu Easow Mathew, Tamoghna Biswas, Shabin Fahad & Mitali Patnaik. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Miranda Davies, Lynda Wilton & Saad Shakir. (2013) Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England. Drug Safety 36:4, pages 237-246.
Crossref
Crossref
Catharine A Winstanley. (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. British Journal of Pharmacology 164:4, pages 1301-1321.
Crossref
Crossref
Brandon G. Oberlin, Robert Evan Bristow, Meredith E. Heighton & Nicholas J. Grahame. (2010) Pharmacologic Dissociation Between Impulsivity and Alcohol Drinking in High Alcohol Preferring Mice. Alcoholism: Clinical and Experimental Research 34:8, pages 1363-1375.
Crossref
Crossref
R. Grant SteenR. Grant Steen. 2009. Human Intelligence and Medical Illness. Human Intelligence and Medical Illness
129
147
.
Manijeh Kahbazi, Aboulfazl Ghoreishi, Fatemeh Rahiminejad, Mohammad-Reza Mohammadi, Abbas Kamalipour & Shahin Akhondzadeh. (2009) A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Research 168:3, pages 234-237.
Crossref
Crossref
Shahrokh Amiri, Mohammad-Reza Mohammadi, Mohammad Mohammadi, Gholam-Hossein Nouroozinejad, Manijeh Kahbazi & Shahin Akhondzadeh. (2008) Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:1, pages 145-149.
Crossref
Crossref